MD, DPhil Director, Yale University Center for Digestive Diseases, Associate Professor of Medicine, Yale University School of Medicine
MD Head of Operations, South America
MD Former Senior Vice President, Medical Affairs, Turing Pharmaceuticals
Michael H. Davidson
MD, FACC, FNLA Professor of Medicine, Director of the Lipid Clinic The University of Chicago Pritzker School of Medicine
Wajahat Z. Mehal
Dr. Mehal is currently Associate Professor of Medicine (Digestive Diseases), Director of Yale Weight Loss Program and liver transplantation center. He is Board Certified in Gastroenterology and Internal Medicine. He has well over 75 publications including book chapters focused in hepatology. He is well regarded in the area of hepatology and has played an important role leading the discussion on the therapeutic landscape of weight management. This area has changed with the introduction of new and well tested weight loss medications, and the intra-gastric balloons. The weight loss program Dr. Mehal oversees brings all non-surgical weight loss components into a single place and include lifestyle/dietary interventions, psychological (Mindfulness training), medications, meal replacement (Optifast) and endoscopic approaches (gastric balloon). This Program also has links to specialty clinics such a diabetes, sleep apnea, hepatology, and has a dedicated EPIC department with outcomes tracker capacity so that outcomes can be quantified and associated with different management decisions. Dr. Mehal received his MD, DPhil, and BA from the University of Oxford..
In his current role, Dr. Mehal plays a critical role in helping the field of hepatology evolve in the areas of HIV, weight loss and liver transplant.
Charles Schmidt is a trained Pediatrician with Master and Doctorate degree. He has been practicing and teaching while working in the biopharma for the past 25 years. He had developed and managed successfully big and mediun size CROs in Latin America and at their global level for more than 15 years. His experience also includes leadership roles in Medical Affairs, Pharmacovigilance, and Medical Monitoring in Pharmaceutical companies. Charles has an extensive background in clinical development efforts in many therapeutic areas in LatAm. He is an attending physician in coordinating the post-graduation program in clinical research at Santa Casa Medical School in Sao Paulo – Brazil since 2007. Also, he is the medical manager of the central institute of clinical research at Hospital de Clínicas – Sao Paulo. Charles was the founder and ex-president of the Brazilian Association of CROs and member and ex-director of Brazilian Association of Pharmaceutical Physicians – SBMF.
Julio Casoy has been Senior Vice President of Medical Affairs for Sepracor, Inc. since August 19, 2008. He joined Sepracor from Shire Pharmaceuticals where he served as Senior Vice President of Global Medical Affairs in 2005. Dr. Casoy served as Vice President of Global Medical Affairs, Compliance and Intercontinental Medical Director at Wyeth.
Dr. Casoy received his medical degree from Universidade Federale de Sao Paulo.
Michael H. Davidson
MD, FACC, FNLA
Michael H. Davidson, MD, is Professor of Medicine and Director of Preventive Cardiology at the University of Chicago. Dr. Davidson earned his medical degree from The Ohio State University College of Medicine in Columbus. He then completed his residency and fellowship in cardiology at Rush University Medical Center in Chicago.
An active researcher, Dr. Davidson’s clinical research background encompasses both pharmaceutical and nutritional clinical trials. His extensive research on statins, novel lipid-lowering drugs, and nonpharmacologic risk factor reduction has established him as a key opinion leader in this area. A prolific author and lecturer on lipid disorders, nutrition, and atherosclerosis, Professor Davidson has coordinated more than 1,000 clinical trials in areas of preventive cardiology and published more than 250 articles for leading medical journals and has written 3 books on Lipidology.
Dr. Davidson is board-certified in internal medicine, cardiology, and clinical lipidology. He is a Fellow of the American College of Cardiology and the American College of Chest Physicians. In addition, he was President (2010-2011) of the National Lipid Association. Expertscape ranks Professor Davidson one of the top five lipid experts in the world; he has been named one of the The Best Doctors in America for the past 12 years and was named Father of the Year by the American Diabetes Association in 2010.